Brind.

Wells Fargo maintained a Buy rating on Elevance Health, Inc. on July 6, 2025.

1 report, 0 independent Updated Jul 6

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

SpeculativeNo independent reporting found

Who's involved

What this event is mainly about

Elevance Health, Inc.Wells Fargo

Keep exploring

The entities involved

Elevance Health, Inc.
American healthcare company

Nothing else this week.
Wells Fargo
American multinational banking and financial services company
- Wells Fargo upgraded Sweetgreen stock to overweight from equal weight on September 28, 2026.Mon 16:33
- Capital Research Global Investors acquired and increased its stake in Wells Fargo stock on June 19, 2026.Mon 16:28

Related events

Morgan Stanley and Raymond James Financial raised their price objectives for Elevance Health, Inc. on September 15, 2026.Sep 15
Elevance Health and Privia Health Group are both facing market scrutiny.Sep 11
Shift4 Payments saw a pre-market rise after receiving an upgrade from Wells Fargo, while B.Riley maintained a buy rating.Aug 25

Coverage

Newest first; wire copies grouped

Jul 6Unknown outlet